Healthcare utilization and cost of pneumococcal disease in the United States-Reference-Cited by-同舟云学术

Healthcare utilization and cost of pneumococcal disease in the United States

Published:2011-04 Issue:18 Volume:29 Page:3398-3412
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Huang Susan S.,Johnson Kristen M.,Ray G. Thomas,Wroe Peter,Lieu Tracy A.,Moore Matthew R.,Zell Elizabeth R.,Linder Jeffrey A.,Grijalva Carlos G.,Metlay Joshua P.,Finkelstein Jonathan A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations;Butler;J Am Med Assoc,1993

2. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine;Shapiro;N Engl J Med,1991

3. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine – United States, 1997–2006;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2009

4. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine;Lexau;J Am Med Assoc,2005

5. Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine;Whitney;N Engl J Med,2003

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upper respiratory Streptococcus pneumoniae colonization among working-age adults with prevalent exposure to overcrowding;Microbiology Spectrum;2024-08-06

2. Comparison of NEWS2 and PSI as mortality predictors in patients with community acquired pneumonia;Journal of the Pakistan Medical Association;2024-05-24

3. The prostaglandin D2 antagonist asapiprant ameliorates clinical severity in young hosts infected with invasive Streptococcus pneumoniae;Infection and Immunity;2024-05-07

4. Pneumococci Isolated From Children in Community-Based Practice Differ From Isolates Identified by Population- and Laboratory-Based Invasive Disease Surveillance;The Journal of Infectious Diseases;2024-04-09

5. A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants;International Journal of Infectious Diseases;2024-04